US20030104372A1 - Allele specific primer extension - Google Patents
Allele specific primer extension Download PDFInfo
- Publication number
- US20030104372A1 US20030104372A1 US09/791,190 US79119001A US2003104372A1 US 20030104372 A1 US20030104372 A1 US 20030104372A1 US 79119001 A US79119001 A US 79119001A US 2003104372 A1 US2003104372 A1 US 2003104372A1
- Authority
- US
- United States
- Prior art keywords
- extension
- primer
- nucleic acid
- target nucleic
- allele
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108700028369 Alleles Proteins 0.000 title claims abstract description 76
- 238000000034 method Methods 0.000 claims abstract description 55
- 102000007347 Apyrase Human genes 0.000 claims description 69
- 108010007730 Apyrase Proteins 0.000 claims description 69
- 239000002773 nucleotide Substances 0.000 claims description 47
- 125000003729 nucleotide group Chemical group 0.000 claims description 47
- 238000006243 chemical reaction Methods 0.000 claims description 34
- 238000009396 hybridization Methods 0.000 claims description 31
- 238000003556 assay Methods 0.000 claims description 30
- 230000000295 complement effect Effects 0.000 claims description 29
- 102000039446 nucleic acids Human genes 0.000 claims description 19
- 108020004707 nucleic acids Proteins 0.000 claims description 19
- 150000007523 nucleic acids Chemical class 0.000 claims description 19
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 18
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 18
- 102000004190 Enzymes Human genes 0.000 claims description 18
- 108090000790 Enzymes Proteins 0.000 claims description 18
- 239000011541 reaction mixture Substances 0.000 claims description 18
- 238000002493 microarray Methods 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 16
- 230000000593 degrading effect Effects 0.000 claims description 12
- 238000012175 pyrosequencing Methods 0.000 claims description 12
- 238000004949 mass spectrometry Methods 0.000 claims description 4
- 239000007790 solid phase Substances 0.000 claims description 3
- 230000035772 mutation Effects 0.000 abstract description 4
- 230000007614 genetic variation Effects 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 42
- 239000000523 sample Substances 0.000 description 40
- 238000003752 polymerase chain reaction Methods 0.000 description 32
- 239000000047 product Substances 0.000 description 22
- 102000053602 DNA Human genes 0.000 description 20
- 230000001404 mediated effect Effects 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 12
- 239000011324 bead Substances 0.000 description 12
- 108020004682 Single-Stranded DNA Proteins 0.000 description 11
- 238000011534 incubation Methods 0.000 description 11
- LWSYSCQGRROTHV-UHFFFAOYSA-N CC.CCC Chemical compound CC.CCC LWSYSCQGRROTHV-UHFFFAOYSA-N 0.000 description 10
- PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 10
- 0 *CC.CCC Chemical compound *CC.CCC 0.000 description 9
- 108020004705 Codon Proteins 0.000 description 9
- 108010020950 Integrin beta3 Proteins 0.000 description 9
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 9
- 108091034117 Oligonucleotide Proteins 0.000 description 8
- 108700025694 p53 Genes Proteins 0.000 description 8
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 6
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 6
- 238000003205 genotyping method Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 5
- 238000000018 DNA microarray Methods 0.000 description 5
- 108010007577 Exodeoxyribonuclease I Proteins 0.000 description 5
- 108060002716 Exonuclease Proteins 0.000 description 5
- 108010030837 Methylenetetrahydrofolate Reductase (NADPH2) Proteins 0.000 description 5
- 102000005954 Methylenetetrahydrofolate Reductase (NADPH2) Human genes 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 230000002950 deficient Effects 0.000 description 5
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 5
- 235000011180 diphosphates Nutrition 0.000 description 5
- 102000013165 exonuclease Human genes 0.000 description 5
- 230000005291 magnetic effect Effects 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 102100029075 Exonuclease 1 Human genes 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 4
- 108010090804 Streptavidin Proteins 0.000 description 4
- IRLPACMLTUPBCL-FCIPNVEPSA-N adenosine-5'-phosphosulfate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@@H](CO[P@](O)(=O)OS(O)(=O)=O)[C@H](O)[C@H]1O IRLPACMLTUPBCL-FCIPNVEPSA-N 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 238000000137 annealing Methods 0.000 description 4
- 229960002685 biotin Drugs 0.000 description 4
- 239000011616 biotin Substances 0.000 description 4
- 229940098773 bovine serum albumin Drugs 0.000 description 4
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 230000005257 nucleotidylation Effects 0.000 description 4
- 102000054765 polymorphisms of proteins Human genes 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 102100032999 Integrin beta-3 Human genes 0.000 description 3
- 101150019913 MTHFR gene Proteins 0.000 description 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 238000003491 array Methods 0.000 description 3
- 210000003050 axon Anatomy 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 102100039819 Actin, alpha cardiac muscle 1 Human genes 0.000 description 2
- YSZUKWLZJXGOTF-UHFFFAOYSA-N CCC.CCC Chemical compound CCC.CCC YSZUKWLZJXGOTF-UHFFFAOYSA-N 0.000 description 2
- MDHLZXOWDPQGHF-RUYBYMOESA-N CCC.C[3H]C Chemical compound CCC.C[3H]C MDHLZXOWDPQGHF-RUYBYMOESA-N 0.000 description 2
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 101000959247 Homo sapiens Actin, alpha cardiac muscle 1 Proteins 0.000 description 2
- 108060001084 Luciferase Proteins 0.000 description 2
- 239000005089 Luciferase Substances 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 102000004523 Sulfate Adenylyltransferase Human genes 0.000 description 2
- 108010022348 Sulfate adenylyltransferase Proteins 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000005298 paramagnetic effect Effects 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- FMKJUUQOYOHLTF-OWOJBTEDSA-N (e)-4-azaniumylbut-2-enoate Chemical compound NC\C=C\C(O)=O FMKJUUQOYOHLTF-OWOJBTEDSA-N 0.000 description 1
- VLEIUWBSEKKKFX-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O VLEIUWBSEKKKFX-UHFFFAOYSA-N 0.000 description 1
- 241000143060 Americamysis bahia Species 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- LWSYSCQGRROTHV-WMTCLNHOSA-N CCC.[3H]CC Chemical compound CCC.[3H]CC LWSYSCQGRROTHV-WMTCLNHOSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 101100361108 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) eas gene Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 238000007844 allele-specific PCR Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000012148 binding buffer Substances 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229940094991 herring sperm dna Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000002761 liquid phase assay Methods 0.000 description 1
- 238000007403 mPCR Methods 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000007857 nested PCR Methods 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000002974 pharmacogenomic effect Effects 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
Definitions
- SNPs single nucleotide polymorphisms
- mapping linkage studies
- pharmacogenomics a number of different techniques have been proposed to scan these sequence variations in a high-throughput fashion. Many of these methods originate from hybridization techniques to discriminate between allelic variants.
- High-throughput hybridization of allele-specific oligonucleotides can be performed on microarray chips (Wang et al. (1998) Science 280:1077), microarray gels (Yershov et al. (1996) Proc. Natl. Acad. Sci.
- the alternating primer is designed to match one allele perfectly but mismatch the other allele at the 3′-end. Because the polymerase differs in extension efficiency for matched versus mismatched 3′-ends, the allele-specific extension reaction thus provides information on the presence or absence of one allele.
- the present invention solves the deficiencies of the prior art by providing a method of allele-specific extension that allows accurate discrimination between matched and mismatched configurations.
- the present methods are useful for high throughput SNP analysis.
- the presence invention provides methods of allele-specific primer extension useful for detecting mutations and genomic variations.
- a nucleotide degrading enzyme preferably apyrase
- nucleotides are degraded before extension in reactions having slow kinetics due to mismatches, but not in reactions having fast kinetics due to matches of primer and allelic target.
- the primers for the allele-specific primer extension reactions are designed such that the 3′-end base is complementary to the target, the penultimate (3′-1 end) base is allele-specific, and the base two positions from the 3′-end (3′-2 end) is the same as (i.e. non-complementary to) the target.
- the primer target duplex is stable and extension occurs.
- two mismatches are present (at the 3′-1 and 3′-2 positions), duplex stability is disrupted and no detectable extension occurs.
- FIG. 1 depicts the results of allele-specific extension for the three variants of the single nucleotide polymorphisms codon 72 (p53) and wiaf 1764.
- the SNP status, which was determined separately for each sample, and the extension primers are shown at the top of the Figure.
- FIG. 1 a shows the raw data obtained using the luminometric assay without apyrase (top panel) and with apyrase (lower panel).
- the arrows point out the signal of pyrophosphate (0.02 ⁇ M) which was added to the reaction mixture prior to the nucleotide addition in all samples to serve as a positive control as well as for peak calibration.
- FIG. 1B shows the extension results of these samples using fluorescently labeled nucleotides spotted on a glass slide, with apyrase (lower panel) and without apyrase (top panel).
- FIG. 2 is a schematic depiction of a method of apyrase mediated allele specific extension using barcodes as tags on the 5′-ends of allele-specific primers.
- FIG. 3 is a schematic depiction of a method of allele-specific extension in solution followed by hybridization to a DNA microarray.
- FIG. 4 is a schematic depiction of an apyrase mediated allele specific reaction in which Taq Man probes are used to measure primer extension.
- FIG. 5 depicts raw data of an apyrase mediated allele specific reaction utilizing a microarray format.
- FIG. 6 depicts bioluminometric analysis of a SNP by double allele-specific primer extension on double stranded DNA.
- FIG. 7 depicts allele specific extension using a primer having an introduced mismatch.
- the present invention relates to methods for detecting bases in a nucleic acid target.
- the present methods are useful for detecting mutations and genomic variations, and particularly single nucleotide polymorphisms (SNPs), and may be used with single stranded or double stranded DNA targets.
- SNPs single nucleotide polymorphisms
- the present invention provides a method of detecting a base at a predetermined position in a DNA molecule.
- the method utilizes DNA polymerase catalyzed primer extension. Pairs of primers are designed that are specific for (i.e. complementary to) an allele of interest, but that differ at the 3′-terminus, which position corresponds to the polymorphic nucleotide.
- the 3′-terminus is complementary to the non-mutated nucleotide; in the other primer, the 3′-terminus is complementary to the mutated nucleotide.
- the primers are used in separate extension reactions of the same sample.
- the 3′-terminus of the primer will be a match or mismatch for the target.
- the DNA polymerase discriminates between a match and mismatch, and exhibits faster reaction kinetics when the 3′-terminus of the primer matches the template.
- measurement of the difference in primer extension efficiency by the DNA polymerase of a matched over a mismatched 3′-terminus allows the determination of a non-mutated versus mutated target sequence.
- the addition of a nucleotide degrading enzyme in the extension reaction minimizes the extension of mismatched primer configurations by removal of nucleotides before incorporation but allows extension when reaction kinetics are fast, i.e. in a matched configuration.
- the present invention thus reduces or eliminates false positive results seen in prior art methods.
- samples may be prepared, primers synthesized, and primer-extension reactions conducted by methods known in the art, and disclosed for example by Higgins et al. (1997) Biotechniques 23:710; Newton et al. (1989) Lancet 2:1481; Goergen et al. (1994) J. Med. Virol. 43:97; and Newton et al. (1989) Nucleic Acids Res. 17:2503, the disclosures of which are incorporated by reference.
- SNP sites may be amplified prior to analysis, for example by PCR, including nested and multiplex PCR.
- SNP containing templates may be immobilized.
- the nucleotide degrading enzyme is preferably added after primer hybridization and preferably with the extension reaction mixture.
- a thermostable nucleotide degrading enzyme is used for PCR reactions.
- the nucleotide degrading enzyme is apyrase, which is commercially available, for example from Sigma Chemical Co., St. Louis, Mo. USA.
- apyrase which is commercially available, for example from Sigma Chemical Co., St. Louis, Mo. USA.
- Those of ordinary skill in the art can determine a suitable amount of apyrase or other nucleotide degrading enzyme to degrade unincorporated nucleotides in extension reactions having slow kinetics due to a mismatch at the 3′-terminus of the primer.
- a typical 50 ⁇ l extension reaction mixture may contain for 1 to 15 mU, and preferably from 5 to 10 mU, of apyrase.
- primer extension can be measured, and thus the ratio of extension using the primer having a matched 3′-terminus and extension using the primer having an unmatched 3′-terminus determined, by methods known in the art. If two primers are used in each reaction, PCR products can be generated and measured. Other methods of measuring primer extension include mass spectroscopy (Higgins et al. (1997) Biotechniques 23:710), luminometric assays, in which incorporation of nucleotides is monitored in real-time using an enzymatic cascade, (Nyren et al. (1997) Anal. Biochem.
- the present method may be performed in a solid phase microarray format, for example on a chip, whereby samples are extended in solution followed by hybridization to a microarray.
- FIG. 3 Allele-specific primer extension on microarrays is known in the art and described for example by Pastinen et al. (2000) Genome Research 10:1031.
- the method may also be performed a liquid phase assay using barcodes as tags on the 5′-ends of allele-specific primers as described by Fan et al. (2000) Genome Res. 10:853.
- a liquid-phase multiplex apyrase mediated allele specific extension of a set of SNPs may be performed in a single tube (if the barcodes on the matched and mismatched primers are different) or in two tubes (if the barcodes on the matched and mismatched primers are identical).
- the extension products can be hybridized to barcodes on the chip.
- a modular probe as described by O'Meara et al. (1998) Anal. Biochem. 255:195 and O'Meara et al. (1998) J. Clin. Microbiol. 36:2454 may be utilized to improve the hybridization efficiency.
- the modular probe hybridizes to its complementary segment on the immobilized oligonucleotide and improves the hybridization of a barcode that is immediately downstream.
- the present method may also be performed using “Taq Man” probes, which are probes labeled with a donor-acceptor dye pair that functions via fluorescence resonance transfer energy (FRET) as described by Livak et al. (1995) PCR Methods Appl. 4:357.
- FRET fluorescence resonance transfer energy
- a Taq Man probe is used which hybridizes 15 to 20 bases downstream of a 3′-end allele-specific primer. Apyrase-mediated allele specific extension is then performed.
- DNA polymerase extends the primer and degrades the Taq Man probe by its 5′-nuclease activity, thus leading to increased donor fluorescence.
- apyrase degrades the nucleotides and the fluorescence level remains unchanged.
- FIG. 4 Such an assay is depicted in FIG. 4.
- Extension products may also be distinguished by mass difference or by the use of double-stranded-specific intercalating dyes.
- allele specific primer extension with a nucleotide degrading enzyme is performed using a double stranded DNA template. If double stranded DNA is generated by PCR, the excess of primers, nucleotides and other reagents must first be removed by methods known in the art such as treatment with alkaline phosphatase and exonuclease I. Two pairs of allele-specific primers are used. One pair is complementary to the forward strand and one to the reverse strand. The primer pairs differ in their 3′-ends as described above. Allele-specific extension is performed on both strands of the double-stranded DNA.
- allele specific extension is performed using a pair of primers in which the 3′-end base is complementary to the target, the penultimate (3′-1 end) base is allele-specific (mutated or nonmutated) and the base two positions from the 3′-end (3′-2 end) is the same as (i.e. non-complementary to) the target.
- the allele-specific base in the primer matches the target template, i.e. one mismatch is present (2 bases from the 3′-end)
- the primer-target duplex is stable and extension occurs.
- the allele-specific base does not match the target, i.e.
- the assay may be performed in all the embodiments as described above, in the presence or absence of a nucleotide degrading enzyme. An example of the method is depicted in FIG. 7.
- the outer and inner amplification mixtures comprised of 10 mM Tris-HCl (pH 8.3), 2 mM MgCl 2 , 50 mM KCl, 0.1% (v/v) Tween 20, 0.2 mM dNTPs, 0.1 ⁇ M of each primer and 1 unit of AmpliTaq DNA polymerase (Perkin-Elmer, Norwalk, Conn., USA) in a total volume of 50 ⁇ l. Five microliters of total human DNA (1 ng/ ⁇ l) were used as outer PCR template. In the inner PCR, one of the primers in the respective set was biotinylated at the 5′-end to allow immobilization.
- the immobilized strand was resuspended in 32 ⁇ l H 2 O and 4 ⁇ l annealing buffer (100 mM Tris-acetate pH 7.75, 20 mM Mg-acetate).
- the single stranded DNA was divided into two parallel reactions in a microtiter-plate (18 ⁇ l/well) and 0.1 ⁇ M (final concentration) of primers were added to the single stranded templates in a total volume of 20 ⁇ l. Allele discrimination between the allelic variants was investigated by the use of Klenow DNA polymerase using two separate SNP primers that only differed in the 3′-end position (Table 1). Hybridization was performed by incubation at 72° C. for 5 min and then cooling to room temperature.
- the extension reaction mixture contained 10 U exonuclease-deficient (exo-) Klenow DNA polymerase (Amersham Pharmacia Biotech, Uppsala, Sweden), 4 ⁇ g purified luciferase/ml (BioThema, Dalarö, Sweden), 15 mU recombinant ATP sulfurylase, 0.1 M Tris-acetate (pH 7.75), 0.5 mM EDTA, 5 mM Mg-acetate, 0.1% (w/v) bovine serum albumin (BioThema), 1 mM dithiothreitol, 10 ⁇ M adenosine 5′-phosphosulfate (APS), 0.4 mg polyvinylpyrrolidone/ml (360 000), 100 ⁇ g D-luciferin/ml (BioThema) and 8 mU of apyrase (Sigma Chemical Co., St.
- pyrophosphate Prior to nucleotide addition and measuring of emitted light, pyrophosphate (PPi) was added to the reaction mixture (0.02 ⁇ M). The PPi served as a positive control for the reaction mixture as well as peak calibration. All the four nucleotides (Amersham Pharmacia Biotech, Uppsala, Sweden) were mixed and were dispensed to the extension mixture (1.4 ⁇ M, final concentration). The emitted light was detected in real-time.
- PPi pyrophosphate
- the single stranded templates were prepared using magnetic beads as outlined above.
- the immobilized strand was resuspended in 100 ⁇ l H 2 O and 12 ⁇ l annealing buffer (100 mM Tris-acetate pH 7.75, 20 mM Mg-acetate).
- the single stranded DNA was divided into two parallel reactions in a microtiter-plate (56 ⁇ l/well) and 0.1 ⁇ M (final concentration) of primers (Table 1) were added to the single stranded templates in a total volume of 60 ⁇ l. Hybridization was performed by incubation at 72° C. for 5 min and then cooling to room temperature.
- the reaction mixture was then further divided into two separate reactions (30 ⁇ l) for direct comparison of the extensions with and without apyrase.
- the extension mixture contained 20 U exonuclease-deficient (exo-) Klenow DNA polymerase (Amersham Pharmacia Biotech), Tris-acetate (pH 7.75), 0.5 mM EDTA, 5 mM Mg-acetate, 0.1% (w/v) bovine serum albumin (BioThema), 1 mM dithiothreitol and optionally 8 mU of apyrase (Sigma Chemical Co.) in a total volume of 70 ⁇ l.
- the extension mixture also contained nucleotides, dATP, dGTP, dTTP and dCTP (1.4 ⁇ M final concentration), where dCTP was labeled with Cy5 or Cy3 (Amersham Pharmacia Biotech).
- the reaction was carried out for 15 min at room temperature.
- the resulting extension products were washed twice with Tris-EDTA and the non-biotinylated extension products were isolated by adding 25 ⁇ l 0.1 M NaOH.
- the eluted strand was neutralized by 12.5 ⁇ l 0.2 M HCl and was printed on a glass slide by the GMS 417 Arrayer (Genetic MicroSystem, USA) and then was scanned using GMS 418 Scanner (Genetic MicroSystem, USA).
- the obtained results were analyzed using GenePix2.0 software (Axon Instruments, USA).
- the amplicons of wiaf 1764 were immobilized onto streptavidin coated beads as outlined above.
- the biotinylated inner primer was primer 3 and not primer 4 (Table 1) with the reason that for this assay the eluted strand is the extension substrate, thus to have the same match and mismatch configurations, the biotinylated inner primer was changed.
- the immobilized PCR product of wiaf 1764 was incubated in 20 ⁇ l 0.1 M NaOH for 5 min.
- the eluted strand was neutralized by 10 ⁇ l 0.2 M HCl and 4 ⁇ l annealing buffer (100 mM Tris-acetate pH 7.75, 20 mM Mg-acetate) was added.
- the eluted and neutralized single stranded DNA was divided into two parallel reactions in a microtiter-plate (17 ⁇ l/well) and extension primers (0.1 ⁇ M) were added. Hybridization was performed by incubation at 72° C. for 5 min and then cooling to room temperature. Here, the extension primers were modified to have amino groups at the 5′-end to allow covalent binding to pre-activated Silyated Slides (Cel Associates Inc, Texas, USA). In order to improve hybridization and extension the primers were extended with a 15-mer spacer (T 15 ) in the 5′-end (Table 1).
- One microliter of the primer-template hybrid was manually spotted on Silyated Slides (Cel Associates Inc) and the covalent coupling was performed in a humid chamber at 37° C. for 16 h. After coupling, 1 mU apyrase (1 ⁇ l) was added to each spot. A polymerization mixture was prepared and 4 ⁇ l was added to the spots immediately after addition of apyrase.
- the polymerization mixture contained Tris-acetate (pH 7.75), 0.5 mM EDTA, 5 mM Mg-acetate, 0.1% (w/v) bovine serum albumin (BioThema), 1 mM dithiothreitol, 0.08 ⁇ M (final concentration) dCTP labeled with Cy3 (Amersham Pharmacia Biotech) and 1 U exonuclease-deficient (exo-) Klenow DNA polymerase (Amersham Pharmacia Biotech). Polymerization was allowed to proceed for 15 min and the microarray slide was washed briefly with water and then scanned using GMS 418 Scanner (Genetic MicroSystem, USA). The data was analyzed by using GenePix2.0 software (Axon Instruments, USA).
- the assays included a luminometric assay and two assays based on fluorescent labeled nucleotides. All the results obtained with these assays were confirmed by pyrosequencing.
- Four SNPs with the eight alternative 3′-end primer-template configurations were investigated (Table 1 and Table 2). The SNPs were codon 72 of the p53 gene (C or G), wiaf 1764 (G or T), nucleotide position 677 in the MTHFR gene (C or T) and nucleotide position 196 in the GPIIIa gene (G or A).
- FIG. 1A shows the results of the luminometric assay with and without apyrase, for codon 72 of the p53 gene and wiaf 1764.
- codon 72 is homozygous G (sample g1) (see Table 2)
- the mismatch signal is as high as the match signal but the slope of the curve indicates slower reaction kinetics (FIG. 1A top panel, extension 2).
- the same was observed for wiaf 1764 homozygous T (sample g055) (see Table 2).
- apyrase was included in the allele-specific extension of these samples (FIG. 1A, lower panel) a dramatic difference was observed.
- the previous high signals for mismatch configurations disappeared with the addition of apyrase.
- the extension ratios were calculated by taking the ratio of the high versus the low end-point signals.
- the ratio for sample g1 in the p53 gene was 1.1 without apyrase and 13.9 with apyrase and for the sample g055 in wiaf 1764 the ratio was 1 without apyrase and 5 with apyrase (Table 2). This clearly shows that addition of apyrase affects the extension and simplifies interpretation.
- an extension ratio below or equal to 2 was interpreted as a sample being heterozygous. If the ratio was above or equal to 2.5 the SNP was scored as homozygous with the nucleotide at the 3′-end of the primer that produced the higher signal.
- Ratios between 2 and 2.5 were interpreted as uncertain. As shown in FIG. 1A and Table 2, in all cases with addition of apyrase the extension signals and extension ratios resulted in a correct genotype with the luminometric assay as compared to the pyrosequencing data. In fact, the extension ratios for all heterozygous SNPs were between 1.1 and 1.4 and the lowest extension ratio for a homozygous sample was 5. In contrast, without the inclusion of apyrase, five out of eight mismatches contributed with so high extension signals that the SNPs were wrongly scored (ratios in bold). The primer-template mismatches that were extended in these cases were G-G, C-T, G-T, T-G and C-A.
- FIG. 1B also shows the raw data of similar extensions on DNA immobilized on magnetic beads using fluorescent detection using a labeled nucleotide instead of a luminometric detection system.
- extension is performed by the same polymerase and the same primers, meaning that the discrimination behavior should be as in the luminometric assay.
- the results are in good agreement with the luminometric assay (Table 2). Without apyrase the same mismatches gave high fluorescent signals leading to that the same homozygous samples were wrongly scored as heterozygous (ratios in bold in Table 2). However in presence of apyrase, no ambiguities or discordant results were observed (FIG. 1B lower panel and Table 2).
- FIG. 5 shows the raw-data of the analysis without and with apyrase.
- a direct comparison of the raw data obtained for samples of wiaf 1764 using both assays shows that the results of extension on chip are correct when apyrase is used while the same homozygous sample as in the other two assays (g055) has led to a high mismatch signal when apyrase was not used.
- a major advantage of using apyrase mediated allele specific extension is that the technique is applicable for high throughput genotyping.
- the present method may also be performed using barcodes (Fan et al. (2000) Genome Res. 10:853) as tags on the 5′-ends of allele-specific primers.
- barcodes Fran et al. (2000) Genome Res. 10:853
- a multiplex AMASE of a set of SNPs is performed in a single tube (if the barcodes on the match and mismatch are different) or in two tubes (if the barcodes on the match and mismatch are identical).
- the double-stranded AMASE products are heat separated and hybridized to barcode complementary oligonucleotides on the chip (FIG. 2).
- a modular probe is utilized (O'Meara et al. (1998) J. Clin. Microbiol. 36:2454).
- the modular probe can hybridize to its complementary segment of the immobilized oligonucleotide and improve the hybridization of barcode that is immediately downstream.
- this example shows that single nucleotide polymorphisms can rapidly be scored with allele-specific primers in extension reactions. Furthermore, the present method can be used in a high-throughput format using microarrays. TABLE 1 List of the primers.
- AASE allele-specific extension
- Amino linked oligonucleotide capture probes suspended at a concentration of 20 ⁇ M in 3 ⁇ SSC/0.01% sakrosyl were spotted using a GMS 418 arrayer (Affymetrix, USA) on silylated slides (CEL Associates, Houston, Tex.).
- GMS 418 arrayer Affymetrix, USA
- Printed arrays were allowed to dry for 12 hours at room temperature followed by post processing to reduce unreacted aldehyde groups thereby minimising non-specific binding of target. Briefly the slides were washed twice in 0.2% SDS for 2 minutes, twice in dH 2 O for 2 minutes and treated with sodium borohydride (0.75 g NaBH 4 dissolved in 225 ml PBS and 75 ml 100% ethanol) for 5 minutes.
- the arrays were then washed in 0.2% SDS three times for 1 minute, rinsed in H2O and dried by centrifugation for 1 minute at 500 g. Prior to use in hybridization, the arrays were prehybridized with buffer containing 5 ⁇ Denharts solution, 6 ⁇ SSC, 0.5% SDS and 0.1 ⁇ g/ ⁇ l herring sperm DNA at 50° C. for 15 minutes followed by a brief rinse in dH 2 O.
- the capture probes were synthesised with an amino group at the 5′ end to facilitate covalent immobilisation on the glass slide.
- a carbon spacer was also synthesised at the 3′ end to prevent any possible extension of the capture probe during hybridization, albeit unlikely due to the high salt conditions.
- the sequences of the capture probes and the allele specific extension primers are listed in Table 3.
- PCR was carried out on human genomic DNA as previously described (Ahmadian et al. (2000) Anal. Biochem. 280:103)) to amplify 3 SNPs.
- the SNPs were codon 72 (C/G) in the p53 gene, nucleotide position 677 (C/T) in the methylenetetrahydrofolate reductase (MTHFR) gene and nucleotide position 196 (A/G) on the glycoprotein IIIa (GP3a) gene.
- C/G codon 72
- MTHFR methylenetetrahydrofolate reductase
- A/G glycoprotein IIIa
- the biotinylated PCR-products ( ⁇ 80 bp) were immobilised onto streptavidin-coated paramagnetic beads (Dynabeads® M-280, Dynal, Oslo, Norway) and by strand-specific elution a pure template for extension was obtained. Briefly, 100 ⁇ l of the PCR-products was captured by incubation for 15 minutes at room temperature with 5 mg/ml of beads in 100 ⁇ l binding/washing buffer (10 mM Tris-HCl (pH 7.5) 1 mM EDTA, 2 M NaCl, 1 mM ⁇ -mercaptoethanol, 0.1% Tween® 20).
- the strands were separated by incubation with 4 ⁇ l of 0.1 M NaOH for 5 minutes.
- the alkaline supernatant with the non-biotinylated strand was neutralised with 2.2 ⁇ l of 0.17 mM HCl and 1 ⁇ l of 100 mM Tris-Acetate pH 7.5, 20 mM MgAc 2 .
- the single strand DNA prepared above was divided into two aliquots and 2.5 pmoles of allele specific primers were annealed by incubation at 72° C. for 5 minutes in a volume of 20 ⁇ l.
- the annealed primer-DNA template was then further divided into two separate reactions for direct comparison of extension with and without apyrase.
- multiplex extension was performed, single strand DNA from the 3 templates was mixed and allele specific primers were annealed.
- Extension was performed in solution on 10 ⁇ l of the annealed DNA (corresponds to 25 ul of each PCR product) in a 60 ⁇ l volume containing 100 mM Tris-Acetate, 0.5 mM EDTA and 5 mM Mg-acetate with 1.4 ⁇ M pmoles of cy5 labelled dNTPs, 2.5 ⁇ g BSA, 1.25 mM DTT, 10 Units exonuclease-deficient (exo-) Klenow DNA polymerase and optionally 8 mU apyrase.
- PCR product One hundred and sixty microlitres of PCR product was treated with 16 Units of calf alkaline phosphatase and 32 Units exonuclease I at room temperature for 30 minutes.
- the enzymes were inactivated by incubation at 95° C. for 12 minutes and the DNA was divided into two aliquots and annealed to 5 pmoles of allele specific primers (incubation at 95° C. for 2 minutes followed by incubation at 72° C. for 5 minutes) in a volume of 100 ⁇ l.
- the annealed primer-DNA template was then further divided into two separate reactions for direct comparison of extension with and without apyrase.
- Extension was carried out on 50 ⁇ l of annealed double strand DNA (corresponds to 40 ⁇ l PCR product) in a 100 ⁇ l as described above. Following incubation at RT for 15 minutes, 25 ⁇ l 20 ⁇ SSC and 12 ⁇ l 10% SDS was added to the extension mixture and 100 ⁇ l was hybridized to the slide as described above.
- the slides were scanned at optimal laser/PMT values using the GMS 417 scanner (Affymetrix, USA) and the features quantitated using GenePix 2.0 software (Axon Instruments, USA). Since different extension/hybridization experiments were compared, the micorarray data was subjected to a normalization procedure. This involved including a 66 mer oligonucleotide control and 18 mer extension probe (Table 3) together with the target DNA that was subjected to extension and hybridization. Since the intensity of this control should be constant from slide to slide it was used to normalize the slides for comparative purposes. Extension ratios were calculated by taking the ratio of the high versus the low signal.
- Results of AMASE for simultaneous genotyping of 3 SNPs on DNA microarrays are shown in Table 4. Inclusion of apyrase resulted in the correct genotype being called in all cases. However when apyrase was omitted, SNPs were incorrectly genotyped in 3 samples (illustrated in boldface type) if the criteria of a ratio ⁇ 2.5 is required to call a homozygous genotype and ⁇ 1.5 for a heterozygous sample. Two replicates of each feature were spotted which allows an estimation of the variability of the method and the standard deviation for each feature is shown in Table 4.
- PCR amplification of wiaf 1764 was performed as described in the foregoing examples.
- the excess of primers, nucleotides and the released PPi in the PCR had to be removed.
- the enzymes shrimp alkaline phosphatase (4 U) (Roche Diagnostics) and E. coli exonuclease I (8 U) (Amersham Pharmacia Biotech, Uppsala, Sweden) were added to 40 ⁇ l of each PCR product.
- Shrimp alkaline phosphatase was used to degrade PPi and the dNTPs while exonuclease I removed single-stranded DNA molecules including PCR primers. The enzymatic degradation was allowed to proceed for 30 min at room temperature. The mixtures were then heated to 97° C. for 12 min to deactivate the enzymes. The samples were divided into two tubes (20 ⁇ l in each) and pairs of allele-specific primer (0.25 ⁇ M) (one complementary to the forward strand and one complementary to the reverse strand) were added into each tube.
- the sequence of primers was A-forward TACAACACTCCCTTCAGATC A , A-reverse TACCATTTGTTAAGCTTTTG T , C-forward TACA ACACTCCCTTCAGATC C and C-reverse ACCATTTGTTAAGCTTTTG G .
- the primer pairs in different tubes differed only in their 3′-ends (underlined bases indicate the alternating 3′-ends) to allow discrimination by allele-specific extension using DNA polymerase. After addition of primers, the samples were incubated at 97° C. for 2 min and then cooled to room temperature, allowing hybridization of allele-specific primer pairs. The content of each well was then further divided into two separate reactions for comparison of extension analysis with and without apyrase.
- Extension and real-time luminometric monitoring was performed at 25° C. in a Luc96 pyrosequencer instrument (Pyrosequencing, Uppsala, Sweden). An extension reaction mixture was added to the samples (10 ⁇ l) with annealed primers (the substrate) to a final volume of 50 ⁇ l.
- the extension reaction mixture contained 10 U exonuclease-deficient (exo-) Klenow DNA polymerase (Amersham Pharmacia Biotech, Uppsala, Sweden), 4 ⁇ g purified luciferase/ml (BioThema, Dalarö, Sweden), 15 mU recombinant ATP sulfurylase, 0.1 M Tris-acetate (pH 7.75), 0.5 mM EDTA, 5 mM Mg-acetate, 0.1% (w/v) bovine serum albumin (BioThema), 1 mM dithiothreitol, 10 ⁇ M adenosine 5′-phosphosulfate (APS), 0.4 mg polyvinylpyrrolidone/ml (360 000), 100 ⁇ g D-luciferin/ml (BioThema) and 8 mU of apyrase (Sigma Chemical Co., St.
- pyrophosphate was added to the reaction mixture (0.08 ⁇ M).
- the PPi served as a positive control for the reaction mixture as well as peak calibration.
- All the four nucleotides (Amersham Pharmacia Biotech, Uppsala, Sweden) were mixed and were dispensed to the extension mixture (0.8 ⁇ M, final concentration). The emitted light was detected in real-time.
- FIG. 6 shows the results of bioluminometric analysis of wiaf 1764.
- the SNP wiaf 1764 has the variants G and/or T (C and/or A).
- Two pairs of allele-specific primers were used to analyze this SNP, one complementary to the forward strand and one complementary to the reverse strand.
- the primer pairs differed in their 3′-ends to allow discrimination by allele-specific extension using DNA polymerase, (extension 1 and extension 2 in FIG. 6).
- extension 1 and extension 2 in FIG. 6
- Prior to hybridization of allele-specific primers the PCR products were treated by shrimp alkaline phosphatase and exonuclease I to remove the excess of primers, nucleotides and PPi.
- the advantage of using two primers in AMASE is that these can be utilized in a PCR amplification assay when a thermostable nucleotide-degrading enzyme (e.g. alkaline phosphatase) is available.
- a thermostable nucleotide-degrading enzyme e.g. alkaline phosphatase
- a perfectly match primer pair will give rise to amplification while mismatch primer pair will not.
- the PCR products are directly analyzed by a luminometric assay since the same primer pair is used in allele-specific extension.
- Another advantage of using two allele-specific primers is that the sensitivity increases by a factor of two because signals of two extensions are obtained instead of one.
- the present example describes a method of allele-specific extension using apyrase and an introduced mismatch in the allele-specific primer, with non-stringent conditions for extension.
- PCR amplification of GPIIIa gene was performed as described in the foregoing examples.
- the SNP in the GPIIIa gene has the variants C/T (G/A).
- the PCR products were immobilized on magnetic beads and single-stranded DNA was obtained by alkaline treatment as described in the foregoing examples.
- the immobilized single-stranded DNA was used as target template in the assay.
- Two different primers were designed. The sequence of primers was CTG TCT TAC AGG CCC TGC CTG C G for GPIIIC and CTG TCT TAC AGG CCC TGC CTG T G for GPIIIT.
- the immobilized strand was resuspended in 32 ⁇ l H 2 O and 4 ⁇ l annealing buffer (100 mM Tris-acetate pH 7.75, 20 mM Mg-acetate).
- the single stranded DNA was divided into two parallel reactions in a microtiter-plate (18 ⁇ l/well) and 0.2 ⁇ M (final concentration) of primers were added to the single stranded templates in a total volume of 20 ⁇ l.
- the primers were designed so that the 3′-end was one base after the SNP site and was complementary to the target DNA (indicated in italics).
- the base before the 3′-end (3′-1) was complementary to the SNP variants and was the only difference between the two allele-specific primers (underlined bases).
- the base before the SNP site (3′-2) on both primers (indicated in bold) was an introduced mismatch to the target DNA (G on the primers and G on the target DNA). Therefore, when the allele-specific base in the primer does not match to the target template, two mismatches (positions 3′-1 and 3′-2) and one match (position 3′) will be made between the template and the last 3 bases in the primer (FIG. 7).
- the allele-specific primer contains a matching base to the target DNA at the 3′-1 position (T to A match)
- two complementary bases are made (at 3′-1 and 3′ position) between the primer and template.
- the mismatch base at position 3′-2 does not remove the two complementary bases at 3′-1 and 3′, which leads to extension.
- sample 1267 that is homozygous G.
- both allele-specific bases are complementary to the respective variant and give rise to extension signals.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The present invention provides methods of allele-specific primer extension useful for detecting mutations and genetic variations.
Description
- This application is a continuation-in-part of U.S. application Ser. No. 09/331,517, which is a 371 of PCT/GB97/03518 filed Dec. 22, 1997, the disclosure of which is incorporated herein by reference.
- Analysis of single nucleotide polymorphisms (SNPs) is useful in applications including mapping, linkage studies and pharmacogenomics. Consequently, a number of different techniques have been proposed to scan these sequence variations in a high-throughput fashion. Many of these methods originate from hybridization techniques to discriminate between allelic variants. High-throughput hybridization of allele-specific oligonucleotides can be performed on microarray chips (Wang et al. (1998) Science 280:1077), microarray gels (Yershov et al. (1996) Proc. Natl. Acad. Sci. USA 93:4913), or by using allele-specific probes (molecular beacons) in the polymerase chain reaction (PCR) (Tyagi et al. (1998) Nat. Biotechnol. 16:49). Other technologies which have been shown to be useful for SNP genotyping are minisequencing (Pastinen et al. (1997) Genome Res. 7:606), mass spectrometry (Laken et al. (1998) Nat. Biotechnol. 16:1352) and pyrosequencing (Ahmadian et al. (2000) Anal. Biochem. 280:103), the latter relying on incorporation of nucleotides by DNA polymerase with an enzymatic cascade converting the released pyrophosphate (PPi) into detectable light.
- The use of pairs of allele-specific primers with alternative bases at the 3′ end has been used to identify single base variations. Higgins et al. (1997) Biotechniques 23:710; Newton et al. (1989) Lancet 2:1481; Goergen et al. (1994) J. Med. Virol. 43:97; and Newton et al. (1989) Nucleic Acids Res. 17:2503. This method exploits the difference in primer extension efficiency by a DNA polymerase of a matched over a
mismatched primer 3′-end. Generally, a sample is divided into two extension reaction mixtures that contain the same reagents except for the primers, which differ at the 3′-end. The alternating primer is designed to match one allele perfectly but mismatch the other allele at the 3′-end. Because the polymerase differs in extension efficiency for matched versus mismatched 3′-ends, the allele-specific extension reaction thus provides information on the presence or absence of one allele. - The foregoing method of identifying single base variations using allele-specific primers with varying 3′-ends suffers from certain deficiencies. In particular, certain mismatches, such as G:T and C:A, are poorly discriminated by the DNA polymerase, leading to false positive signals (Day et al. (1999) Nucleic Acids Res. 27:1810). In these cases, DNA polymerase extends the mismatched primer-templates in the presence of nucleotides although, as the present inventors have shown, with slower reaction kinetics as compared to extension of the matched configuration. However, the kinetic difference is usually not distinguishable in end point analysis, such as allele-specific PCR.
- The present invention solves the deficiencies of the prior art by providing a method of allele-specific extension that allows accurate discrimination between matched and mismatched configurations. The present methods are useful for high throughput SNP analysis.
- The presence invention provides methods of allele-specific primer extension useful for detecting mutations and genomic variations. In one embodiment, a nucleotide degrading enzyme, preferably apyrase, is included in the allele-specific primer reaction. In this method, nucleotides are degraded before extension in reactions having slow kinetics due to mismatches, but not in reactions having fast kinetics due to matches of primer and allelic target.
- In another embodiment, the primers for the allele-specific primer extension reactions are designed such that the 3′-end base is complementary to the target, the penultimate (3′-1 end) base is allele-specific, and the base two positions from the 3′-end (3′-2 end) is the same as (i.e. non-complementary to) the target. When one mismatch is present (2 bases from the 3-end) the primer target duplex is stable and extension occurs. However, when two mismatches are present (at the 3′-1 and 3′-2 positions), duplex stability is disrupted and no detectable extension occurs.
- FIG. 1 depicts the results of allele-specific extension for the three variants of the single nucleotide polymorphisms codon 72 (p53) and
wiaf 1764. The SNP status, which was determined separately for each sample, and the extension primers are shown at the top of the Figure. FIG. 1a shows the raw data obtained using the luminometric assay without apyrase (top panel) and with apyrase (lower panel). The arrows point out the signal of pyrophosphate (0.02 μM) which was added to the reaction mixture prior to the nucleotide addition in all samples to serve as a positive control as well as for peak calibration. FIG. 1B shows the extension results of these samples using fluorescently labeled nucleotides spotted on a glass slide, with apyrase (lower panel) and without apyrase (top panel). - FIG. 2 is a schematic depiction of a method of apyrase mediated allele specific extension using barcodes as tags on the 5′-ends of allele-specific primers.
- FIG. 3 is a schematic depiction of a method of allele-specific extension in solution followed by hybridization to a DNA microarray.
- FIG. 4 is a schematic depiction of an apyrase mediated allele specific reaction in which Taq Man probes are used to measure primer extension.
- FIG. 5 depicts raw data of an apyrase mediated allele specific reaction utilizing a microarray format.
- FIG. 6 depicts bioluminometric analysis of a SNP by double allele-specific primer extension on double stranded DNA.
- FIG. 7 depicts allele specific extension using a primer having an introduced mismatch.
- The present invention relates to methods for detecting bases in a nucleic acid target. The present methods are useful for detecting mutations and genomic variations, and particularly single nucleotide polymorphisms (SNPs), and may be used with single stranded or double stranded DNA targets.
- In one embodiment, the present invention provides a method of detecting a base at a predetermined position in a DNA molecule. The method utilizes DNA polymerase catalyzed primer extension. Pairs of primers are designed that are specific for (i.e. complementary to) an allele of interest, but that differ at the 3′-terminus, which position corresponds to the polymorphic nucleotide. In one primer, the 3′-terminus is complementary to the non-mutated nucleotide; in the other primer, the 3′-terminus is complementary to the mutated nucleotide. The primers are used in separate extension reactions of the same sample. Depending upon whether the mutation is present, the 3′-terminus of the primer will be a match or mismatch for the target. The DNA polymerase discriminates between a match and mismatch, and exhibits faster reaction kinetics when the 3′-terminus of the primer matches the template. Thus measurement of the difference in primer extension efficiency by the DNA polymerase of a matched over a mismatched 3′-terminus allows the determination of a non-mutated versus mutated target sequence. In accordance with the present invention it has been found that the addition of a nucleotide degrading enzyme in the extension reaction minimizes the extension of mismatched primer configurations by removal of nucleotides before incorporation but allows extension when reaction kinetics are fast, i.e. in a matched configuration. The present invention thus reduces or eliminates false positive results seen in prior art methods.
- In accordance with the present invention, samples may be prepared, primers synthesized, and primer-extension reactions conducted by methods known in the art, and disclosed for example by Higgins et al. (1997) Biotechniques 23:710; Newton et al. (1989) Lancet 2:1481; Goergen et al. (1994) J. Med. Virol. 43:97; and Newton et al. (1989) Nucleic Acids Res. 17:2503, the disclosures of which are incorporated by reference. SNP sites may be amplified prior to analysis, for example by PCR, including nested and multiplex PCR. SNP containing templates may be immobilized.
- The nucleotide degrading enzyme is preferably added after primer hybridization and preferably with the extension reaction mixture. For PCR reactions, a thermostable nucleotide degrading enzyme is used.
- In a preferred embodiment of the present method, the nucleotide degrading enzyme is apyrase, which is commercially available, for example from Sigma Chemical Co., St. Louis, Mo. USA. Those of ordinary skill in the art can determine a suitable amount of apyrase or other nucleotide degrading enzyme to degrade unincorporated nucleotides in extension reactions having slow kinetics due to a mismatch at the 3′-terminus of the primer. For example, a typical 50 μl extension reaction mixture may contain for 1 to 15 mU, and preferably from 5 to 10 mU, of apyrase.
- In the present invention, primer extension can be measured, and thus the ratio of extension using the primer having a matched 3′-terminus and extension using the primer having an unmatched 3′-terminus determined, by methods known in the art. If two primers are used in each reaction, PCR products can be generated and measured. Other methods of measuring primer extension include mass spectroscopy (Higgins et al. (1997) Biotechniques 23:710), luminometric assays, in which incorporation of nucleotides is monitored in real-time using an enzymatic cascade, (Nyren et al. (1997) Anal. Biochem. 244:367), fluorescent assays using dye-labeled nucleotides, or pyrosequencing as described by Ronaghi et al. (1998) Science 281:363, and Ahmadian et al. (2000) Anal. Biochem. 280:103.
- The present method may be performed in a solid phase microarray format, for example on a chip, whereby samples are extended in solution followed by hybridization to a microarray. (FIG. 3). Allele-specific primer extension on microarrays is known in the art and described for example by Pastinen et al. (2000) Genome Research 10:1031. The method may also be performed a liquid phase assay using barcodes as tags on the 5′-ends of allele-specific primers as described by Fan et al. (2000) Genome Res. 10:853. By using barcodes, a liquid-phase multiplex apyrase mediated allele specific extension of a set of SNPs may be performed in a single tube (if the barcodes on the matched and mismatched primers are different) or in two tubes (if the barcodes on the matched and mismatched primers are identical). After primer extension, the extension products can be hybridized to barcodes on the chip. A modular probe as described by O'Meara et al. (1998) Anal. Biochem. 255:195 and O'Meara et al. (1998) J. Clin. Microbiol. 36:2454 may be utilized to improve the hybridization efficiency. The modular probe hybridizes to its complementary segment on the immobilized oligonucleotide and improves the hybridization of a barcode that is immediately downstream.
- The present method may also be performed using “Taq Man” probes, which are probes labeled with a donor-acceptor dye pair that functions via fluorescence resonance transfer energy (FRET) as described by Livak et al. (1995) PCR Methods Appl. 4:357. When Taq Man probes are hybridized to a target, the fluorescence of the 5′-donor fluorophore is quenched by the 3′-acceptor. When the hybridized probe is degraded, the 5′-donor dye dissociates from the 3′-quencher, leading to an increase in donor fluorescence.
- After PCR amplification, a Taq Man probe is used which hybridizes 15 to 20 bases downstream of a 3′-end allele-specific primer. Apyrase-mediated allele specific extension is then performed. In the case of a matched primer-template, DNA polymerase extends the primer and degrades the Taq Man probe by its 5′-nuclease activity, thus leading to increased donor fluorescence. In the mismatched case, apyrase degrades the nucleotides and the fluorescence level remains unchanged. Such an assay is depicted in FIG. 4.
- Extension products may also be distinguished by mass difference or by the use of double-stranded-specific intercalating dyes.
- In another embodiment of the present invention, allele specific primer extension with a nucleotide degrading enzyme is performed using a double stranded DNA template. If double stranded DNA is generated by PCR, the excess of primers, nucleotides and other reagents must first be removed by methods known in the art such as treatment with alkaline phosphatase and exonuclease I. Two pairs of allele-specific primers are used. One pair is complementary to the forward strand and one to the reverse strand. The primer pairs differ in their 3′-ends as described above. Allele-specific extension is performed on both strands of the double-stranded DNA.
- In another embodiment of the present invention, allele specific extension is performed using a pair of primers in which the 3′-end base is complementary to the target, the penultimate (3′-1 end) base is allele-specific (mutated or nonmutated) and the base two positions from the 3′-end (3′-2 end) is the same as (i.e. non-complementary to) the target. When the allele-specific base in the primer matches the target template, i.e. one mismatch is present (2 bases from the 3′-end), the primer-target duplex is stable and extension occurs. When the allele-specific base does not match the target, i.e. two mismatches are present (at the 3′-1 and 3′-2 positions), duplex stability is disrupted and no detectable extension occurs. The assay may be performed in all the embodiments as described above, in the presence or absence of a nucleotide degrading enzyme. An example of the method is depicted in FIG. 7.
- All references cited herein are incorporated herein in their entirety.
- The following non-limiting examples serve to further illustrate the present invention.
- Experimental Protocol
- Samples, PCR and Single Strand Preparation
- Human genomic DNA was extracted from twenty-four unrelated individuals. Two duplex PCRs were performed to amplify four SNPs. The SNPs were wiaf1764 (A/C) on chromosome 9q, codon 72 (C/G) on the p53 gene (Ahmadian et al. (2000) Anal. Biochem. 280:103) nucleotide position 677 (C/T) on the MTHFR gene (Goyette et al. (1998) Mamm. Genome 9:652, erratum in (1999) Mamm. Genome 10:204) and nucleotide position 196 (A/G) on the GPIIIa gene (Newman et al. (1989) J. Clin. Invst. 83:1778). The outer duplex PCR for
wiaf 1764 and p53 gene (94° C. 1 min, 50° C. 40s and 72° C. 2 min for 35 cycles) was followed by specific inner PCRs (94° C. 1 min, 50° C. 40s and 72° C. 1 min for 35 cycles) generating ˜80 bp fragments for each SNP (Table 1). The outer duplex PCR condition for MTHFR and GPIIIa genes was 95° C. 30s, 60° C. 1 min and 72° C. 1 min. This was followed by individual inner PCRs (95° C. 1 min, 66° C. 50 sec and 72° C. 2 min) (Table 1). The outer and inner amplification mixtures comprised of 10 mM Tris-HCl (pH 8.3), 2 mM MgCl2, 50 mM KCl, 0.1% (v/v) Tween 20, 0.2 mM dNTPs, 0.1 μM of each primer and 1 unit of AmpliTaq DNA polymerase (Perkin-Elmer, Norwalk, Conn., USA) in a total volume of 50 μl. Five microliters of total human DNA (1 ng/μl) were used as outer PCR template. In the inner PCR, one of the primers in the respective set was biotinylated at the 5′-end to allow immobilization. 40 μl biotinylated inner PCR products were immobilized onto streptavidin-coated super paramagnetic beads (Dynabeads M280; Dynal, Oslo, Norway). Single-stranded DNA was obtained by incubating the immobilized PCR product in 12 μl 0.1 M NaOH for 5 min. The immobilized strand was then used for hybridization to extension primers (Table 1). - Apyrase Mediated Allele-specific Extension Using a Bioluminometric Assay
- The immobilized strand was resuspended in 32 μl H2O and 4 μl annealing buffer (100 mM Tris-acetate pH 7.75, 20 mM Mg-acetate). The single stranded DNA was divided into two parallel reactions in a microtiter-plate (18 μl/well) and 0.1 μM (final concentration) of primers were added to the single stranded templates in a total volume of 20 μl. Allele discrimination between the allelic variants was investigated by the use of Klenow DNA polymerase using two separate SNP primers that only differed in the 3′-end position (Table 1). Hybridization was performed by incubation at 72° C. for 5 min and then cooling to room temperature. The content of each well was then further divided into two separate reactions for comparison of extension analysis with and without apyrase. Extension and real-time luminometric monitoring was performed at 25° C. in a Luc96 pyrosequencer instrument (Pyrosequencing, Uppsala, Sweden). An extension reaction mixture was added to the single stranded DNA (10 μl) with annealed primer (the substrate) to a final volume of 50 μl. The extension reaction mixture contained 10 U exonuclease-deficient (exo-) Klenow DNA polymerase (Amersham Pharmacia Biotech, Uppsala, Sweden), 4 μg purified luciferase/ml (BioThema, Dalarö, Sweden), 15 mU recombinant ATP sulfurylase, 0.1 M Tris-acetate (pH 7.75), 0.5 mM EDTA, 5 mM Mg-acetate, 0.1% (w/v) bovine serum albumin (BioThema), 1 mM dithiothreitol, 10
μM adenosine 5′-phosphosulfate (APS), 0.4 mg polyvinylpyrrolidone/ml (360 000), 100 μg D-luciferin/ml (BioThema) and 8 mU of apyrase (Sigma Chemical Co., St. Louis, Mo., USA) when applicable. Prior to nucleotide addition and measuring of emitted light, pyrophosphate (PPi) was added to the reaction mixture (0.02 μM). The PPi served as a positive control for the reaction mixture as well as peak calibration. All the four nucleotides (Amersham Pharmacia Biotech, Uppsala, Sweden) were mixed and were dispensed to the extension mixture (1.4 μM, final concentration). The emitted light was detected in real-time. - Apyrase Mediated Allele-specific Extension Using Fluorescent Labeled Nucleotide
- The single stranded templates were prepared using magnetic beads as outlined above. The immobilized strand was resuspended in 100 μl H2O and 12 μl annealing buffer (100 mM Tris-acetate pH 7.75, 20 mM Mg-acetate). The single stranded DNA was divided into two parallel reactions in a microtiter-plate (56 μl/well) and 0.1 μM (final concentration) of primers (Table 1) were added to the single stranded templates in a total volume of 60 μl. Hybridization was performed by incubation at 72° C. for 5 min and then cooling to room temperature. The reaction mixture was then further divided into two separate reactions (30 μl) for direct comparison of the extensions with and without apyrase. The extension mixture contained 20 U exonuclease-deficient (exo-) Klenow DNA polymerase (Amersham Pharmacia Biotech), Tris-acetate (pH 7.75), 0.5 mM EDTA, 5 mM Mg-acetate, 0.1% (w/v) bovine serum albumin (BioThema), 1 mM dithiothreitol and optionally 8 mU of apyrase (Sigma Chemical Co.) in a total volume of 70 μl. The extension mixture also contained nucleotides, dATP, dGTP, dTTP and dCTP (1.4 μM final concentration), where dCTP was labeled with Cy5 or Cy3 (Amersham Pharmacia Biotech). The reaction was carried out for 15 min at room temperature. The resulting extension products were washed twice with Tris-EDTA and the non-biotinylated extension products were isolated by adding 25 μl 0.1 M NaOH. The eluted strand was neutralized by 12.5 μl 0.2 M HCl and was printed on a glass slide by the GMS 417 Arrayer (Genetic MicroSystem, USA) and then was scanned using GMS 418 Scanner (Genetic MicroSystem, USA). The obtained results were analyzed using GenePix2.0 software (Axon Instruments, USA).
- Apyrase Mediated Allele-specific Extension Using Fluorescent Labeled Nucleotide Evaluated in a Microarray Format
- After amplification, the amplicons of
wiaf 1764 were immobilized onto streptavidin coated beads as outlined above. The biotinylated inner primer wasprimer 3 and not primer 4 (Table 1) with the reason that for this assay the eluted strand is the extension substrate, thus to have the same match and mismatch configurations, the biotinylated inner primer was changed. The immobilized PCR product ofwiaf 1764 was incubated in 20 μl 0.1 M NaOH for 5 min. The eluted strand was neutralized by 10 μl 0.2 M HCl and 4 μl annealing buffer (100 mM Tris-acetate pH 7.75, 20 mM Mg-acetate) was added. The eluted and neutralized single stranded DNA was divided into two parallel reactions in a microtiter-plate (17 μl/well) and extension primers (0.1 μM) were added. Hybridization was performed by incubation at 72° C. for 5 min and then cooling to room temperature. Here, the extension primers were modified to have amino groups at the 5′-end to allow covalent binding to pre-activated Silyated Slides (Cel Associates Inc, Texas, USA). In order to improve hybridization and extension the primers were extended with a 15-mer spacer (T15) in the 5′-end (Table 1). One microliter of the primer-template hybrid was manually spotted on Silyated Slides (Cel Associates Inc) and the covalent coupling was performed in a humid chamber at 37° C. for 16 h. After coupling, 1 mU apyrase (1 μl) was added to each spot. A polymerization mixture was prepared and 4 μl was added to the spots immediately after addition of apyrase. The polymerization mixture contained Tris-acetate (pH 7.75), 0.5 mM EDTA, 5 mM Mg-acetate, 0.1% (w/v) bovine serum albumin (BioThema), 1 mM dithiothreitol, 0.08 μM (final concentration) dCTP labeled with Cy3 (Amersham Pharmacia Biotech) and 1 U exonuclease-deficient (exo-) Klenow DNA polymerase (Amersham Pharmacia Biotech). Polymerization was allowed to proceed for 15 min and the microarray slide was washed briefly with water and then scanned using GMS 418 Scanner (Genetic MicroSystem, USA). The data was analyzed by using GenePix2.0 software (Axon Instruments, USA). - Pyrosequencing
- Single stranded DNA with annealed sequence primer (the substrate) (Table 1) were used for pyrosequencing. Real-time pyrosequencing was performed at 28° C. in a total volume of 50 μl in an automated 96-well PyroSequencer using PSQ™ SNP 96 enzymes and substrates (Pyrosequencing AB, Uppsala, Sweden).
- Results
- Two different approaches of apyrase mediated allele-specific extensions were investigated. The assays included a luminometric assay and two assays based on fluorescent labeled nucleotides. All the results obtained with these assays were confirmed by pyrosequencing. Four SNPs with the eight alternative 3′-end primer-template configurations were investigated (Table 1 and Table 2). The SNPs were codon 72 of the p53 gene (C or G), wiaf 1764 (G or T), nucleotide position 677 in the MTHFR gene (C or T) and nucleotide position 196 in the GPIIIa gene (G or A). Thus, using two alternative allele-specific primers for each SNP, the following mismatches were possible; G-G and C-C for codon 72 (p53 gene), A-G and C-T for
wiaf 1764, A-C and G-T for polymorphic position on the MTHFR gene, T-G and C-A for the SNP on the GPIIIa gene (Table 2). - FIG. 1A shows the results of the luminometric assay with and without apyrase, for
codon 72 of the p53 gene andwiaf 1764. Whencodon 72 is homozygous G (sample g1) (see Table 2), the mismatch signal is as high as the match signal but the slope of the curve indicates slower reaction kinetics (FIG. 1A top panel, extension 2). The same was observed forwiaf 1764 homozygous T (sample g055) (see Table 2). However, when apyrase was included in the allele-specific extension of these samples (FIG. 1A, lower panel) a dramatic difference was observed. The previous high signals for mismatch configurations, disappeared with the addition of apyrase. The extension ratios were calculated by taking the ratio of the high versus the low end-point signals. For example, the ratio for sample g1 in the p53 gene was 1.1 without apyrase and 13.9 with apyrase and for the sample g055 inwiaf 1764 the ratio was 1 without apyrase and 5 with apyrase (Table 2). This clearly shows that addition of apyrase affects the extension and simplifies interpretation. In these assays an extension ratio below or equal to 2 was interpreted as a sample being heterozygous. If the ratio was above or equal to 2.5 the SNP was scored as homozygous with the nucleotide at the 3′-end of the primer that produced the higher signal. Ratios between 2 and 2.5 were interpreted as uncertain. As shown in FIG. 1A and Table 2, in all cases with addition of apyrase the extension signals and extension ratios resulted in a correct genotype with the luminometric assay as compared to the pyrosequencing data. In fact, the extension ratios for all heterozygous SNPs were between 1.1 and 1.4 and the lowest extension ratio for a homozygous sample was 5. In contrast, without the inclusion of apyrase, five out of eight mismatches contributed with so high extension signals that the SNPs were wrongly scored (ratios in bold). The primer-template mismatches that were extended in these cases were G-G, C-T, G-T, T-G and C-A. FIG. 1B also shows the raw data of similar extensions on DNA immobilized on magnetic beads using fluorescent detection using a labeled nucleotide instead of a luminometric detection system. Thus, extension is performed by the same polymerase and the same primers, meaning that the discrimination behavior should be as in the luminometric assay. The results (extension ratios) are in good agreement with the luminometric assay (Table 2). Without apyrase the same mismatches gave high fluorescent signals leading to that the same homozygous samples were wrongly scored as heterozygous (ratios in bold in Table 2). However in presence of apyrase, no ambiguities or discordant results were observed (FIG. 1B lower panel and Table 2). - The foregoing example demonstrates that apyrase aids in the discrimination of mismatches in allele-specific extension. The extensions in these cases were performed on magnetic beads. The use of this technology in a microarray format was also evaluated. The
SNP wiaf 1764 were amplified in 3 samples (g011, 119 and g055) and single stranded templates were obtained by immobilization of the PCR product onto magnetic beads. The eluted non-biotinylated strand was used in the subsequent extension experiments. Extension primers were modified to have a free amino group in the 5′-end as well as a 15 nucleotide long oligo dT spacer. The extension primers and the single strand target were hybridized, printed and then covalently coupled to the activated glass slides. The extension reaction mixtures were then added to microarray. FIG. 5 shows the raw-data of the analysis without and with apyrase. A direct comparison of the raw data obtained for samples ofwiaf 1764 using both assays shows that the results of extension on chip are correct when apyrase is used while the same homozygous sample as in the other two assays (g055) has led to a high mismatch signal when apyrase was not used. - As shown above, a major advantage of using apyrase mediated allele specific extension (AMASE) is that the technique is applicable for high throughput genotyping. The present method may also be performed using barcodes (Fan et al. (2000) Genome Res. 10:853) as tags on the 5′-ends of allele-specific primers. In this way a multiplex AMASE of a set of SNPs is performed in a single tube (if the barcodes on the match and mismatch are different) or in two tubes (if the barcodes on the match and mismatch are identical). After performance of AMASE, the double-stranded AMASE products are heat separated and hybridized to barcode complementary oligonucleotides on the chip (FIG. 2). To improve the hybridization efficiency, at the hybridization step a modular probe is utilized (O'Meara et al. (1998) J. Clin. Microbiol. 36:2454). The modular probe can hybridize to its complementary segment of the immobilized oligonucleotide and improve the hybridization of barcode that is immediately downstream.
- In conclusion, this example shows that single nucleotide polymorphisms can rapidly be scored with allele-specific primers in extension reactions. Furthermore, the present method can be used in a high-throughput format using microarrays.
TABLE 1 List of the primers. SNP Primer 5′ 3′ wiaf1764 1 AGTGAAAACATTGAAAACACA 2 AATGTTTTCACTGTCATAAAG 3 TCCAATGTGTGAAAAATATATAC 4-Biotin AGAACACATACGTTTTACCA Extension1 ACTCCCTTCAGATCA Extension2 ACTCCCTTCAGATCC Amino- TTTTTTTTTTTTTTTATACAAC ACTC Extension1 CCTTCAGATCA Amino- TTTTTTTTTTTTTTTATACAAC ACTC Extension2 CCTTCAGATCC Seq CATTTGTTAAGCTTTT p53 codon 1 ATGCTGTCCCCGGACGA 72 2 CAGGAGGGGGCTGGTG 3- Biotin TCCAGATGAAGCTCCCAG 4 AGGGGCCGCCGGTGTA Extension1 GCTGCTGGTGCAGGGGCCACGC Extension2 GCTGCTGCTGCAGGGGCCACGG Seq GCTGCTGGTGCAGGGGCCA mthfr 1 CCTGACTGTCATCCCTATTGGCAG 2 GGGACGATGGGGCAAGTGATG 3- Biotin GCTGACCTGAAGCACTTGAAGGAG 4 GCCTCAAAGAAAAGCTGCGTG Extension1 GCTGCGTGATGATGAAATCGA Extension2 GCTGCGTGATGATGAAATCGG Seq AAGCTGCGTGATGATGAAA 1 GCCATAGCTCTGATTGCTGGACTTC gp3a 2 GCCTCACTCACTGGGAACTCGATG 3 GCTGGACTTCTCTTTGGGCTCCTG 4-Biotin ACAGTTATCCTTCAGCAGATTCTCCTT Extension1 TCTTACAGGCCCTGCCTCC Extension2 TCTTACAGGCCCTGCCTCT Seq CCTGTCTTACAGGCCCTGCC # pyrosequenceing. Notice that when the Amino-Extension primers (for wiaf 1764) are used, the biotinylated inner primer was primer 3 and notprimer 4 -
TABLE 2 Summary of extension results Schematic Allele-Specific Extension Ratio Representation of (high/how) Sequencing Configurations Bioluminescence Fluorescent SNP Sample Result Extension 1 Extension 2− apyrase + apyrase − apyrase + apyrase p53 (G/C) g1 G/G 1.1 13.9 1.2 4.9 116 G/C 1.2 1.1 1.4 1.4 123 C/C 2.6 12 2.3 10.5 wiaf 1764 (G/T) g011 G/G 8.3 8 15.5 3.9 119 T/G 1.2 1.1 1.3 1.5 g055 T/ T 1 5 1.1 8.2 MTHFR (C/T) 1001 C/C 3.5 12 20 35 1055 T/ C 1 1.3 1.1 1.3 1004 T/T 1.1 12 2.3 13 GPIIIa (G/A) 1267 G/G 1.1 6.5 1.1 3.5 1001 G/A 1.2 1.4 1.4 1.1 1055 A/A 1.4 10 1.1 7.1 - Apyrase mediated allele-specific extension (AMASE) for genotyping on DNA microarrays is described in this report. The method involves extension of the DNA samples in solution followed by hybridization to the DNA microarray as illustrated in FIG. 3.
- Materials and Method
- Microarray Preparation
- Amino linked oligonucleotide capture probes suspended at a concentration of 20 μM in 3×SSC/0.01% sakrosyl were spotted using a GMS 418 arrayer (Affymetrix, USA) on silylated slides (CEL Associates, Houston, Tex.). Printed arrays were allowed to dry for 12 hours at room temperature followed by post processing to reduce unreacted aldehyde groups thereby minimising non-specific binding of target. Briefly the slides were washed twice in 0.2% SDS for 2 minutes, twice in dH2O for 2 minutes and treated with sodium borohydride (0.75 g NaBH4 dissolved in 225 ml PBS and 75 ml 100% ethanol) for 5 minutes. The arrays were then washed in 0.2% SDS three times for 1 minute, rinsed in H2O and dried by centrifugation for 1 minute at 500 g. Prior to use in hybridization, the arrays were prehybridized with buffer containing 5×Denharts solution, 6×SSC, 0.5% SDS and 0.1 μg/μl herring sperm DNA at 50° C. for 15 minutes followed by a brief rinse in dH2O.
- Oligonucleotides
- The capture probes were synthesised with an amino group at the 5′ end to facilitate covalent immobilisation on the glass slide. A carbon spacer was also synthesised at the 3′ end to prevent any possible extension of the capture probe during hybridization, albeit unlikely due to the high salt conditions. The sequences of the capture probes and the allele specific extension primers are listed in Table 3.
- DNA Preparation
- PCR was carried out on human genomic DNA as previously described (Ahmadian et al. (2000) Anal. Biochem. 280:103)) to amplify 3 SNPs. The SNPs were codon 72 (C/G) in the p53 gene, nucleotide position 677 (C/T) in the methylenetetrahydrofolate reductase (MTHFR) gene and nucleotide position 196 (A/G) on the glycoprotein IIIa (GP3a) gene. To allow for immobilization of the PCR products on streptavidin beads and preparation of single strand DNA, biotinylated inner PCR primers were used. The biotinylated PCR-products (˜80 bp) were immobilised onto streptavidin-coated paramagnetic beads (Dynabeads® M-280, Dynal, Oslo, Norway) and by strand-specific elution a pure template for extension was obtained. Briefly, 100 μl of the PCR-products was captured by incubation for 15 minutes at room temperature with 5 mg/ml of beads in 100 μl binding/washing buffer (10 mM Tris-HCl (pH 7.5) 1 mM EDTA, 2 M NaCl, 1 mM β-mercaptoethanol, 0.1% Tween® 20). After washing and removal of supernatant, the strands were separated by incubation with 4 μl of 0.1 M NaOH for 5 minutes. The alkaline supernatant with the non-biotinylated strand was neutralised with 2.2 μl of 0.17 mM HCl and 1 μl of 100 mM Tris-Acetate pH 7.5, 20 mM MgAc2.
- Extension and Hybridization
- Single Strand DNA:
- The single strand DNA prepared above was divided into two aliquots and 2.5 pmoles of allele specific primers were annealed by incubation at 72° C. for 5 minutes in a volume of 20 μl. The annealed primer-DNA template was then further divided into two separate reactions for direct comparison of extension with and without apyrase. When multiplex extension was performed, single strand DNA from the 3 templates was mixed and allele specific primers were annealed.
- Extension was performed in solution on 10 μl of the annealed DNA (corresponds to 25 ul of each PCR product) in a 60 μl volume containing 100 mM Tris-Acetate, 0.5 mM EDTA and 5 mM Mg-acetate with 1.4 μM pmoles of cy5 labelled dNTPs, 2.5 μg BSA, 1.25 mM DTT, 10 Units exonuclease-deficient (exo-) Klenow DNA polymerase and optionally 8 mU apyrase. Following incubation of the extension products at room temperature for 15 minutes, 60 μl 10×SSC/0.4% SDS was added to the extension reactions and 100 μl was then hybridized to the oligonucleotide microarray. Hybridization was performed on the GeneTAC hybridization station (Genomic solutions, MI, USA) at 50° C. for 20 minutes followed by washing in 2×SSC/0.1% SDS for 5 minutes proceeded by washing in 0.6×SSC for a further 5 minutes. The slides were briefly rinsed in H2O and dried by centrifugation at 500 g for 1 minute.
- Double Strand DNA:
- One hundred and sixty microlitres of PCR product was treated with 16 Units of calf alkaline phosphatase and 32 Units exonuclease I at room temperature for 30 minutes. The enzymes were inactivated by incubation at 95° C. for 12 minutes and the DNA was divided into two aliquots and annealed to 5 pmoles of allele specific primers (incubation at 95° C. for 2 minutes followed by incubation at 72° C. for 5 minutes) in a volume of 100 μl. The annealed primer-DNA template was then further divided into two separate reactions for direct comparison of extension with and without apyrase. Extension was carried out on 50 μl of annealed double strand DNA (corresponds to 40 μl PCR product) in a 100 μl as described above. Following incubation at RT for 15 minutes, 25 μl 20×SSC and 12 μl 10% SDS was added to the extension mixture and 100 μl was hybridized to the slide as described above.
- Data Analysis
- The slides were scanned at optimal laser/PMT values using the GMS 417 scanner (Affymetrix, USA) and the features quantitated using GenePix 2.0 software (Axon Instruments, USA). Since different extension/hybridization experiments were compared, the micorarray data was subjected to a normalization procedure. This involved including a 66 mer oligonucleotide control and 18 mer extension probe (Table 3) together with the target DNA that was subjected to extension and hybridization. Since the intensity of this control should be constant from slide to slide it was used to normalize the slides for comparative purposes. Extension ratios were calculated by taking the ratio of the high versus the low signal.
- Results
- Results of AMASE for simultaneous genotyping of 3 SNPs on DNA microarrays are shown in Table 4. Inclusion of apyrase resulted in the correct genotype being called in all cases. However when apyrase was omitted, SNPs were incorrectly genotyped in 3 samples (illustrated in boldface type) if the criteria of a ratio ≧2.5 is required to call a homozygous genotype and ≦1.5 for a heterozygous sample. Two replicates of each feature were spotted which allows an estimation of the variability of the method and the standard deviation for each feature is shown in Table 4. The results in Table 4 are based on extension of single strand DNA while preliminary results for genotyping of double strand DNA gave ratios of 3.9±0.2 (with apyrase) versus 2.7±0.4 (without apyrase) for
codon 72 of the p53 gene (sample g1).TABLE 3 Sequence of capture and extension probes SNP Probe Sequence (5′-3′) Capture TGA AGC TCC CAG AAT GCC P53 probe Extension AGA GGC TGC TCC CCC 1 Extension AGA GGC TGC TCC CCG 2 MTHFR Capture CAG CCT CAA AGA AAA GCT probe Extension GCG TGA TGA TGA AAT CGG 1 Extension GCG TGA TGA TGA AAT CGA 2 GPIIIa Capture CTT CTC TTT GGG CTC CTG probe Extension TCT TAC AGG CCC TGC CTC C 1 Extension TCT TAC AGG CCC TGC CTC T 2 Control Capture GGT GCA CGG TCT ACG AGA probe Extension CCT CCC GGG GCA CTC GCA probe Extension AGG CCT TGT GGT ACT GCC TGG TAG template GGT GCT TGC GAG TGC CCC GGG AGG TCT CGT AGA CCG TGC ACC -
TABLE 4 Genotyping of SNPs on microarrays using AMASE Allele-Specific Extension Ratio (high/low) Sequencing Microarray SNP Sample Result − apyrase + apyrase p53 g1 G/G 1.9 ± 0.2* 8.8 ± 1.6* (G/C) 116 G/C 2.5 ± 0.5* 1.1 ± 0.1* 123 C/C 22.1 ± 0.5 37.9 ± 3.8 THFR 1001 C/C 19.8 ± 1.8 21.8 ± 2.9 (C/T) 1055 T/C nd nd 1004 T/T 21.3 ± 3.7 42 ± 5.1 GPIIIa 1267 G/G 2.2 ± 0.2 6.4 ± 1.6 (G/A) 1001 G/A nd nd 1055 A/A 8.6 ± 0.7 28.3 ± 3.9 - Materials and Methods
- PCR amplification of
wiaf 1764 was performed as described in the foregoing examples. In Order to perform double-strand DNA analysis of this SNP (without strand separation by the use of beads), the excess of primers, nucleotides and the released PPi in the PCR had to be removed. For this purpose, the enzymes shrimp alkaline phosphatase (4 U) (Roche Diagnostics) and E. coli exonuclease I (8 U) (Amersham Pharmacia Biotech, Uppsala, Sweden) were added to 40 μl of each PCR product. Shrimp alkaline phosphatase was used to degrade PPi and the dNTPs while exonuclease I removed single-stranded DNA molecules including PCR primers. The enzymatic degradation was allowed to proceed for 30 min at room temperature. The mixtures were then heated to 97° C. for 12 min to deactivate the enzymes. The samples were divided into two tubes (20 μl in each) and pairs of allele-specific primer (0.25 μM) (one complementary to the forward strand and one complementary to the reverse strand) were added into each tube. The sequence of primers was A-forward TACAACACTCCCTTCAGATCA, A-reverse TACCATTTGTTAAGCTTTTGT, C-forward TACA ACACTCCCTTCAGATCC and C-reverse ACCATTTGTTAAGCTTTTGG. The primer pairs in different tubes differed only in their 3′-ends (underlined bases indicate the alternating 3′-ends) to allow discrimination by allele-specific extension using DNA polymerase. After addition of primers, the samples were incubated at 97° C. for 2 min and then cooled to room temperature, allowing hybridization of allele-specific primer pairs. The content of each well was then further divided into two separate reactions for comparison of extension analysis with and without apyrase. Extension and real-time luminometric monitoring was performed at 25° C. in a Luc96 pyrosequencer instrument (Pyrosequencing, Uppsala, Sweden). An extension reaction mixture was added to the samples (10 μl) with annealed primers (the substrate) to a final volume of 50 μl. The extension reaction mixture contained 10 U exonuclease-deficient (exo-) Klenow DNA polymerase (Amersham Pharmacia Biotech, Uppsala, Sweden), 4 μg purified luciferase/ml (BioThema, Dalarö, Sweden), 15 mU recombinant ATP sulfurylase, 0.1 M Tris-acetate (pH 7.75), 0.5 mM EDTA, 5 mM Mg-acetate, 0.1% (w/v) bovine serum albumin (BioThema), 1 mM dithiothreitol, 10μM adenosine 5′-phosphosulfate (APS), 0.4 mg polyvinylpyrrolidone/ml (360 000), 100 μg D-luciferin/ml (BioThema) and 8 mU of apyrase (Sigma Chemical Co., St. Louis, Mo., USA) when applicable. Prior to nucleotide addition and measuring of emitted light, pyrophosphate (PPi) was added to the reaction mixture (0.08 μM). The PPi served as a positive control for the reaction mixture as well as peak calibration. All the four nucleotides (Amersham Pharmacia Biotech, Uppsala, Sweden) were mixed and were dispensed to the extension mixture (0.8 μM, final concentration). The emitted light was detected in real-time. - Results and Discussion
- FIG. 6 shows the results of bioluminometric analysis of
wiaf 1764. TheSNP wiaf 1764 has the variants G and/or T (C and/or A). Two pairs of allele-specific primers were used to analyze this SNP, one complementary to the forward strand and one complementary to the reverse strand. The primer pairs differed in their 3′-ends to allow discrimination by allele-specific extension using DNA polymerase, (extension 1 andextension 2 in FIG. 6). Prior to hybridization of allele-specific primers the PCR products were treated by shrimp alkaline phosphatase and exonuclease I to remove the excess of primers, nucleotides and PPi. This allowed heat separation of double-stranded DNA and direct analysis of the PCR product without strand separation by using beads. Thus, allele-specific extension was performed on both strands of a double-stranded DNA. The bioluminimetric assay was performed without using apyrase (−apyrase in FIG. 6) and by the use of apyrase (+apyrase in FIG. 6). All three variants ofwiaf 1764 were analyzed and the ratios between the match and mismatch signals were calculated. The ratios are outlined in the bottom of FIG. 6. As it is shown all variants of the SNP could correctly be scored when apyrase was used in the system (ratios - The advantage of using two primers in AMASE is that these can be utilized in a PCR amplification assay when a thermostable nucleotide-degrading enzyme (e.g. alkaline phosphatase) is available. A perfectly match primer pair will give rise to amplification while mismatch primer pair will not. After amplification, the PCR products are directly analyzed by a luminometric assay since the same primer pair is used in allele-specific extension. Another advantage of using two allele-specific primers is that the sensitivity increases by a factor of two because signals of two extensions are obtained instead of one.
- The present example describes a method of allele-specific extension using apyrase and an introduced mismatch in the allele-specific primer, with non-stringent conditions for extension.
- PCR amplification of GPIIIa gene was performed as described in the foregoing examples. The SNP in the GPIIIa gene has the variants C/T (G/A). The PCR products were immobilized on magnetic beads and single-stranded DNA was obtained by alkaline treatment as described in the foregoing examples. The immobilized single-stranded DNA was used as target template in the assay. Two different primers were designed. The sequence of primers was CTG TCT TAC AGG CCC TGC CTGCG for GPIIIC and CTG TCT TAC AGG CCC TGC CTG TG for GPIIIT. The immobilized strand was resuspended in 32 μl H2O and 4 μl annealing buffer (100 mM Tris-acetate pH 7.75, 20 mM Mg-acetate). The single stranded DNA was divided into two parallel reactions in a microtiter-plate (18 μl/well) and 0.2 μM (final concentration) of primers were added to the single stranded templates in a total volume of 20 μl. The primers were designed so that the 3′-end was one base after the SNP site and was complementary to the target DNA (indicated in italics). Thus, the base before the 3′-end (3′-1) was complementary to the SNP variants and was the only difference between the two allele-specific primers (underlined bases). The base before the SNP site (3′-2) on both primers (indicated in bold) was an introduced mismatch to the target DNA (G on the primers and G on the target DNA). Therefore, when the allele-specific base in the primer does not match to the target template, two mismatches (
positions 3′-1 and 3′-2) and one match (position 3′) will be made between the template and the last 3 bases in the primer (FIG. 7). When the allele-specific base in the primer does match to the target template, the last two bases in the 3′-end of the primer (positions 3′and 3′-1) will be complementary to the target DNA while the introduced mismatch (position 3′-2) is not complementary. Raw-data were obtained from a luminometric assay. The conditions (enzymes, substrates etc) of performance of the luminometric assay are as described in the foregoing examples. Prior to nucleotide addition and measurement of emitted light, pyrophosphate (PPi) was added to the reaction mixture (0.02 μM). The PPi served as a positive control for the reaction mixture as well as peak calibration. All three variants of the SNP were investigated with (+apyrase) and without (−apyrase) addition of apyrase (FIG. 7). As shown in FIG. 7, Sample 1055 is homozygous A in the target DNA template. Thus, an allele-specific primer containing the base C at 3′-1 position is a mismatch to the target (C to A mismatch) and since the 3′-2 position is also a mismatch (G to G mismatch), the two mismatches disrupt the hydrogen bind of the match base at the 3′ position of the primer (G to C match) and no extension is observed. When the allele-specific primer contains a matching base to the target DNA at the 3′-1 position (T to A match), two complementary bases are made (at 3′-1 and 3′ position) between the primer and template. In a non-stringent extension condition (extension at 25° C.), the mismatch base atposition 3′-2 does not remove the two complementary bases at 3′-1 and 3′, which leads to extension. The same explanation can be used for sample 1267 that is homozygous G. In the heterozygous case (sample 1001) both allele-specific bases are complementary to the respective variant and give rise to extension signals.
Claims (17)
1. A method for detecting an allele-specific base at a predetermined position in a target nucleic acid molecule comprising providing a first and a second hybridization mixture, said first hybridization mixture comprising said target nucleic acid molecule, and a primer that hybridizes to a region of said target nucleic acid molecule and that has a 3′-terminus that is complementary to a non-mutated base at said predetermined position, said second hybridization mixture comprising said target nucleic acid molecule, and a primer that hybridizes to a region of said target nucleic acid molecule and that has a 3′-terminus that is complementary to a mutated base at said predetermined position; adding a primer extension reaction mixture to each of said first and second hybridization mixtures, said primer extension reaction mixture comprising a DNA polymerase, nucleotides, and a nucleotide degrading enzyme; and determining primer extension efficiency in each of said first and second mixtures, whereby greater efficiency in the mixture comprising the primer having a 3′-terminus that is complementary to the mutated base is indicative of the presence of the mutated base in the target nucleic acid, and whereby greater efficiency in the mixture comprising the primer having a 3′-terminus that is complementary to the non-mutated base is indicative of the presence of the non-mutated base in the target nucleic acid.
2. The method of claim 1 wherein the nucleotide degrading enzyme is apyrase.
3. The method of claim 1 wherein the target nucleic acid is amplified before hybridization.
4. The method of claim 1 wherein the target nucleic acid is immobilized.
5. The method of claim 1 wherein primer extension efficiency is measured by an assay selected from mass spectroscopy, a luminometric assay, a fluorescent assay, and pyrosequencing.
6. The method of claim 1 wherein said method is performed in a solid phase microarray format.
7. The method of claim 1 wherein said primers are tagged on the 5′-ends by barcodes.
8. The method of claim 1 wherein the target nucleic acid is double stranded.
9. A method for detecting an allele-specific base at a predetermined position in a target nucleic acid comprising conducting a first and a second allele-specific primer extension reaction using a first and a second primer, respectively that hybridizes to a region of said target nucleic acid, each of said primers having: 1) a 3′-end base that is complementary to the base that is 5′ of the predetermined position in the target; 2) a base one position from the 3′-end that in the first primer is complementary to a non-mutated based at the predetermined position, and in the second primer is complementary to a mutated base at the predetermined position; and 3) a base two positions from the 3′-end that is the same as the base that is 3′ of the predetermined position in the target; and determining primer extension efficiency in said first and second reactions, whereby greater efficiency in said first reaction is indicative of the presence of a non-mutated base at said predetermined position, and whereby greater efficiency in said second reaction is indicative of the presence of a mutated base at said predetermined position.
10. The method of claim 9 wherein said extension reactions are performed in the presence of a nucleotide degrading enzyme.
11. The method of claim 10 wherein said nucleotide degrading enzyme is apyrase.
12. The method of claim 9 wherein said target nucleic acid is amplified before hybridization.
13. The method of claim 9 wherein said target nucleic acid is immobilized.
14. The method of claim 9 wherein said primer extension efficiency is measured by an assay selected from mass spectroscopy, a luminometric assay, a fluorescent assay, and pyrosequencing.
15. The method of claim 9 wherein said method is performed in a solid phase microarray format.
16. The method of claim 9 wherein said primers are tagged at the 5′-ends by barcodes.
17. The method of claim 9 wherein said target nucleic acid is double stranded.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/791,190 US20030104372A1 (en) | 1996-12-23 | 2001-02-23 | Allele specific primer extension |
AU2002233540A AU2002233540A1 (en) | 2001-02-23 | 2002-02-22 | Allele-specific primer extension assay |
PCT/GB2002/000794 WO2002068684A2 (en) | 2001-02-23 | 2002-02-22 | Allele-specific primer extension assay |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9626815.6A GB9626815D0 (en) | 1996-12-23 | 1996-12-23 | Method of sequencing DNA |
GB9626815.6 | 1996-12-23 | ||
US09/331,517 US6258568B1 (en) | 1996-12-23 | 1997-12-22 | Method of sequencing DNA based on the detection of the release of pyrophosphate and enzymatic nucleotide degradation |
US09/791,190 US20030104372A1 (en) | 1996-12-23 | 2001-02-23 | Allele specific primer extension |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/331,517 Continuation-In-Part US6258568B1 (en) | 1996-12-23 | 1997-12-22 | Method of sequencing DNA based on the detection of the release of pyrophosphate and enzymatic nucleotide degradation |
PCT/GB1997/003518 Continuation-In-Part WO1998028440A1 (en) | 1996-12-23 | 1997-12-22 | Method of sequencing dna based on the detection of the release of pyrophosphate |
Publications (1)
Publication Number | Publication Date |
---|---|
US20030104372A1 true US20030104372A1 (en) | 2003-06-05 |
Family
ID=26310722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/791,190 Abandoned US20030104372A1 (en) | 1996-12-23 | 2001-02-23 | Allele specific primer extension |
Country Status (1)
Country | Link |
---|---|
US (1) | US20030104372A1 (en) |
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040229222A1 (en) * | 2001-03-30 | 2004-11-18 | Buena Chui | P450 single nucleotide polymorphism biochip analysis |
US20060178838A1 (en) * | 2005-02-10 | 2006-08-10 | Adelson Martin E | Method of receiving and handling a plurality of clinical samples for reporting a sum of diagnostic results for each sample |
US20060257874A1 (en) * | 2003-01-14 | 2006-11-16 | Tisi Lawrence C | Method for determining the amount of template nucleic acid present in a sample |
US20080118917A1 (en) * | 2006-11-21 | 2008-05-22 | Applera Corporation | Isothermal SNP Detection Method |
US20080118921A1 (en) * | 2004-07-29 | 2008-05-22 | Lumora Limited | Method for Determining the Amount of Template Nucleic Acid Present in a Sample |
US8501408B2 (en) | 2005-01-06 | 2013-08-06 | Medical Diagnostic Laboratories, Llc | Methods and compositions for detecting and identifying species of Candida |
US9464310B2 (en) | 2005-02-10 | 2016-10-11 | Medical Diagnostic Laboratories, Llc | Integrated method for collection and maintenance of detectability of a plurality of microbiological agents in a single clinical sample and for handling a plurality of samples for reporting a sum of diagnostic results for each sample |
US20170183729A1 (en) * | 2015-12-28 | 2017-06-29 | Phalanx Biotech Group, Inc. | Method of double allele specific pcr for snp microarray |
US20180100191A1 (en) * | 2000-12-01 | 2018-04-12 | Life Technologies Corporation | Enzymatic nucleic acid synthesis: compositions and methods for inhibiting pyrophosphorolysis |
US20180178174A1 (en) * | 2006-05-11 | 2018-06-28 | Raindance Technologies, Inc. | Microfluidic devices |
US10415081B2 (en) * | 2001-10-15 | 2019-09-17 | Bioarray Solutions Ltd. | Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection |
US10808279B2 (en) | 2010-02-12 | 2020-10-20 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
US10927407B2 (en) | 2006-05-11 | 2021-02-23 | Bio-Rad Laboratories, Inc. | Systems and methods for handling microfluidic droplets |
US10960397B2 (en) | 2007-04-19 | 2021-03-30 | President And Fellows Of Harvard College | Manipulation of fluids, fluid components and reactions in microfluidic systems |
US11077415B2 (en) | 2011-02-11 | 2021-08-03 | Bio-Rad Laboratories, Inc. | Methods for forming mixed droplets |
US11168353B2 (en) | 2011-02-18 | 2021-11-09 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
US11174509B2 (en) | 2013-12-12 | 2021-11-16 | Bio-Rad Laboratories, Inc. | Distinguishing rare variations in a nucleic acid sequence from a sample |
US11187702B2 (en) | 2003-03-14 | 2021-11-30 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
US11254968B2 (en) | 2010-02-12 | 2022-02-22 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
US11390917B2 (en) | 2010-02-12 | 2022-07-19 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
US11511242B2 (en) | 2008-07-18 | 2022-11-29 | Bio-Rad Laboratories, Inc. | Droplet libraries |
US11635427B2 (en) | 2010-09-30 | 2023-04-25 | Bio-Rad Laboratories, Inc. | Sandwich assays in droplets |
US11786872B2 (en) | 2004-10-08 | 2023-10-17 | United Kingdom Research And Innovation | Vitro evolution in microfluidic systems |
US11819849B2 (en) | 2007-02-06 | 2023-11-21 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
US11901041B2 (en) | 2013-10-04 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Digital analysis of nucleic acid modification |
US11898193B2 (en) | 2011-07-20 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Manipulating droplet size |
US12038438B2 (en) | 2008-07-18 | 2024-07-16 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
US12140590B2 (en) | 2021-11-17 | 2024-11-12 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
-
2001
- 2001-02-23 US US09/791,190 patent/US20030104372A1/en not_active Abandoned
Cited By (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180100191A1 (en) * | 2000-12-01 | 2018-04-12 | Life Technologies Corporation | Enzymatic nucleic acid synthesis: compositions and methods for inhibiting pyrophosphorolysis |
US6986992B2 (en) * | 2001-03-30 | 2006-01-17 | Amersham Biosciences Ab | P450 single nucleotide polymorphism biochip analysis |
US20040229222A1 (en) * | 2001-03-30 | 2004-11-18 | Buena Chui | P450 single nucleotide polymorphism biochip analysis |
US10415081B2 (en) * | 2001-10-15 | 2019-09-17 | Bioarray Solutions Ltd. | Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection |
US20060257874A1 (en) * | 2003-01-14 | 2006-11-16 | Tisi Lawrence C | Method for determining the amount of template nucleic acid present in a sample |
US7371545B2 (en) | 2003-01-14 | 2008-05-13 | Lumora Limited | Method for determining the amount of template nucleic acid present in a sample |
US11187702B2 (en) | 2003-03-14 | 2021-11-30 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
US20080118921A1 (en) * | 2004-07-29 | 2008-05-22 | Lumora Limited | Method for Determining the Amount of Template Nucleic Acid Present in a Sample |
US8309308B2 (en) | 2004-07-29 | 2012-11-13 | Lumora Limited | Method for determining the amount of template nucleic acid present in a sample |
US11786872B2 (en) | 2004-10-08 | 2023-10-17 | United Kingdom Research And Innovation | Vitro evolution in microfluidic systems |
US8501408B2 (en) | 2005-01-06 | 2013-08-06 | Medical Diagnostic Laboratories, Llc | Methods and compositions for detecting and identifying species of Candida |
US9464310B2 (en) | 2005-02-10 | 2016-10-11 | Medical Diagnostic Laboratories, Llc | Integrated method for collection and maintenance of detectability of a plurality of microbiological agents in a single clinical sample and for handling a plurality of samples for reporting a sum of diagnostic results for each sample |
US20060178838A1 (en) * | 2005-02-10 | 2006-08-10 | Adelson Martin E | Method of receiving and handling a plurality of clinical samples for reporting a sum of diagnostic results for each sample |
US10639597B2 (en) * | 2006-05-11 | 2020-05-05 | Bio-Rad Laboratories, Inc. | Microfluidic devices |
US12091710B2 (en) | 2006-05-11 | 2024-09-17 | Bio-Rad Laboratories, Inc. | Systems and methods for handling microfluidic droplets |
US10625220B2 (en) | 2006-05-11 | 2020-04-21 | Bio-Rad Laboratories, Inc. | Microfluidic devices |
US20180178174A1 (en) * | 2006-05-11 | 2018-06-28 | Raindance Technologies, Inc. | Microfluidic devices |
US11351510B2 (en) | 2006-05-11 | 2022-06-07 | Bio-Rad Laboratories, Inc. | Microfluidic devices |
US10927407B2 (en) | 2006-05-11 | 2021-02-23 | Bio-Rad Laboratories, Inc. | Systems and methods for handling microfluidic droplets |
US20080118917A1 (en) * | 2006-11-21 | 2008-05-22 | Applera Corporation | Isothermal SNP Detection Method |
US11819849B2 (en) | 2007-02-06 | 2023-11-21 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
US11224876B2 (en) | 2007-04-19 | 2022-01-18 | Brandeis University | Manipulation of fluids, fluid components and reactions in microfluidic systems |
US11618024B2 (en) | 2007-04-19 | 2023-04-04 | President And Fellows Of Harvard College | Manipulation of fluids, fluid components and reactions in microfluidic systems |
US10960397B2 (en) | 2007-04-19 | 2021-03-30 | President And Fellows Of Harvard College | Manipulation of fluids, fluid components and reactions in microfluidic systems |
US11511242B2 (en) | 2008-07-18 | 2022-11-29 | Bio-Rad Laboratories, Inc. | Droplet libraries |
US12038438B2 (en) | 2008-07-18 | 2024-07-16 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
US11534727B2 (en) | 2008-07-18 | 2022-12-27 | Bio-Rad Laboratories, Inc. | Droplet libraries |
US11596908B2 (en) | 2008-07-18 | 2023-03-07 | Bio-Rad Laboratories, Inc. | Droplet libraries |
US11254968B2 (en) | 2010-02-12 | 2022-02-22 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
US10808279B2 (en) | 2010-02-12 | 2020-10-20 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
US11390917B2 (en) | 2010-02-12 | 2022-07-19 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
US11635427B2 (en) | 2010-09-30 | 2023-04-25 | Bio-Rad Laboratories, Inc. | Sandwich assays in droplets |
US11077415B2 (en) | 2011-02-11 | 2021-08-03 | Bio-Rad Laboratories, Inc. | Methods for forming mixed droplets |
US11747327B2 (en) | 2011-02-18 | 2023-09-05 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
US11768198B2 (en) | 2011-02-18 | 2023-09-26 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
US11168353B2 (en) | 2011-02-18 | 2021-11-09 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
US11965877B2 (en) | 2011-02-18 | 2024-04-23 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
US11754499B2 (en) | 2011-06-02 | 2023-09-12 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
US11898193B2 (en) | 2011-07-20 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Manipulating droplet size |
US11901041B2 (en) | 2013-10-04 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Digital analysis of nucleic acid modification |
US11174509B2 (en) | 2013-12-12 | 2021-11-16 | Bio-Rad Laboratories, Inc. | Distinguishing rare variations in a nucleic acid sequence from a sample |
US10457989B2 (en) * | 2015-12-28 | 2019-10-29 | Phalanx Biotech Group, Inc. | Method of double allele specific PCR for SNP microarray |
US20170183729A1 (en) * | 2015-12-28 | 2017-06-29 | Phalanx Biotech Group, Inc. | Method of double allele specific pcr for snp microarray |
US12146134B2 (en) | 2018-06-01 | 2024-11-19 | Bio-Rad Laboratories, Inc. | Microfluidic devices and methods of use in the formation and control of nanoreactors |
US12140590B2 (en) | 2021-11-17 | 2024-11-12 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
US12140591B2 (en) | 2022-03-21 | 2024-11-12 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20030104372A1 (en) | Allele specific primer extension | |
US11591641B2 (en) | Methods and compositions for whole genome amplification and genotyping | |
US8003354B2 (en) | Multiplex nucleic acid reactions | |
EP2264188B1 (en) | Methods and compositions for whole genome amplification and genotyping | |
US8288103B2 (en) | Multiplex nucleic acid reactions | |
US5888819A (en) | Method for determining nucleotide identity through primer extension | |
US6537748B1 (en) | Reagent for nucleic acid typing by primer extension | |
US20050181394A1 (en) | Methods and compositions for whole genome amplification and genotyping | |
US20040146866A1 (en) | Quantitative multiplex detection of nucleic acids | |
WO2003066803A2 (en) | Pyrophosphorolysis and incorporation of nucleotide method for nucleic acid detection | |
WO2003020983A1 (en) | Allele specific pcr for genotyping | |
US20090148849A1 (en) | One-step target detection assay | |
WO2002018659A2 (en) | Method for determining alleles | |
WO2002068684A2 (en) | Allele-specific primer extension assay | |
US7262032B2 (en) | Allele-specific mutation detection assay using an enzyme-disabling agent | |
EP2246438A1 (en) | Multiplex nucleic acid reactions | |
US20060008826A1 (en) | Method for determining alleles | |
WO2001048244A2 (en) | Detection of single nucleotide polymorphisms | |
WO2002024960A1 (en) | Detection of dna variation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: PYROSEQUENCING AB, SWEDEN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:AHMADIAN, AFSHIN;LUNDEBERG, JOAKIM;NYREN, PAL;REEL/FRAME:012444/0151;SIGNING DATES FROM 20010606 TO 20011116 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |